Brief: Kancera Decides On Rights Issue Of Units And Warrants Of About SEK 90 Mln
Oct 13 (Reuters) - Kancera KANC.ST :
* SAID ON WEDNESDAY IT HAS DECIDED ON RIGHTS ISSUE OF UNITS
AND
WARRANTS OF ABOUT SEK 90 MLN
* SUBSCRIPTION PRICE AT SEK 24 PER UNIT
* AIM OF THE ISSUE IS TO INTENSIFY INVESTMENT IN CLINICAL
DEVELOPMENT FOR THE TREATMENT OF OVARIAN CANCER
Source text for Eikon: urn:newsml:reuters.com:*:nWkrw4q1j
Further company coverage: KANC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing